Mechanism of Action of Rivastigmine
Introduction Rivastigmine is a centrally acting cholinesterase inhibitor used primarily in Alzheimer disease and Parkinson disease-associated dementia. It improves cognitive function by increasing acetylcholine levels in the brain. Rivastigmine inhibits both acetylcholinesterase and butyrylcholinesterase enzymes, enhancing cholinergic neurotransmission in cortical and hippocampal regions involved in memory and cognition. Mechanism of Action (Step-wise) A key exam … Read more